IL33 and neoplasm: In IL-33-treated mice, intra-tumor NKp46(+) NKG2D(+) and NKp46(+) FasL(+) cells were markedly reduced, while PBS-treated ST2-deficient mice had increased frequencies of these tumoricidal NK cells compared to that in untreated wild-type mice (16).